Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amlodipine/Valsartan vs Exforge in Healthy Volunteers
NCT02519010Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Mar 2011
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine + valsartan in hypertension (HTN) (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time 0 to last measurable concentration and 1 more. Started Mar 2011; status: completed.
02
Drugs
amlodipine + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02519010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519010.